NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/22/24 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 08/21/24 | UPLOAD | SEC-generated letter |
|
2 | |
| 08/13/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
34 |
| 08/12/24 | 8-K | Current report filing |
|
|
6 |
| 08/01/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/23/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/23/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/19/24 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 07/19/24 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
5 | |
| 07/12/24 | 8-K | Current report filing |
|
|
3 |